SlideShare uma empresa Scribd logo
1 de 6
Baixar para ler offline
914
Rapid Diagnosis of Infectious Pleural Effusions by Use of Reagent Strips
Elie Azoulay,1
Muriel Fartoukh,3
Richard Galliot,4
Fre´de´ric Baud,4
Ge´rald Simonneau,3
Jean-Roger
Le Gall,1
Benoıˆt Schlemmer,1
and Sylvie Chevret2
1
Medical Intensive Care Unit and 2
Biostatistics Department, Saint
Louis Teaching Hospital, Paris 7 University, 3
Medical and Respiratory
Intensive Care Unit, Antoine Beclere Teaching Hospital, and 4
Medical
Intensive Care Unit, Lariboisiere Teaching Hospital, Paris, France
Reagent strips have not yet been tested for use in the diagnosis of infectious pleural effusions.
A reagent strip was used to evaluate 82 patients with pleural effusions: 20 patients had tran-
sudative effusions, 35 had infectious exudative effusions (empyema in 14 and parapneumonic
effusion in 21), and 27 had noninfectious exudative effusions. Pleural fluid protein, as eval-
uated by the reagent strip, proved accurate for the detection of exudative effusions (sensitivity,
93.1%; specificity, 50%; positive predictive value, 84.3%; negative predictive value, 71.5%; odds
ratio [OR], 6.77; and 95% confidence interval [CI], 1.87–24). The reagent strip leukocyte es-
terase test effectively detected infectious exudative effusions (sensitivity, 42.8%; specificity,
91.3%; positive predictive value, 88.2%; negative predictive value, 51.2%; OR, 4.46; and 95%
CI, 1.2–16.4). Pleural pH was significantly predicted by the reagent strip but was of no as-
sistance in categorization of exudative effusions as infectious or noninfectious. Compared
with physical, laboratory, and microbiological data, the reagent strip was as accurate for
estimation of percentages of infectious and noninfectious exudative effusions. Thus, reagent
strips may be a rapid, easy-to-use, and inexpensive technique for discriminating transudative
from exudative pleural effusions and for categorizing exudative pleural effusions as infectious
or noninfectious.
A pleural effusion must be characterized as transudative or
exudative and, if exudative, as infectious or noninfectious.
These distinctions are important for choosing the appropriate
management, such as therapy for heart failure, drainage of an
infectious exudative effusion, or microbiological documenta-
tion and adequate antibiotics for empyema. Exploratory thora-
centesis is classically indicated because, in combination with
blood tests, examination of pleural fluid frequently provides the
etiologic diagnosis [1].
Use of reagent strips has been proposed for the rapid di-
agnosis of meningitis, ascites, and urinary tract infections [2–5]
and has also been validated for determination of the pH of
pleural effusions [6, 7]. However, reagent strips have not been
tested for their accuracy in the determination of the levels of
protein and leukocyte esterase in pleural fluid, 2 parameters
that are of paramount importance for distinguishing transu-
dates from exudates and for determining whether an exudate
is due to an infection [8].
We conducted a prospective 3-center study to evaluate the
performance of reagent strips in the diagnosis of pleural infec-
Received 25 October 1999; revised 16 February 2000; electronically pub-
lished 20 October 2000.
The appropriate institutional review board approved the study, and all
patients gave their informed consent.
Reprints or correspondence: Dr. Elie Azoulay, Medical ICU, Saint Louis
Teaching Hospital, 1, avenue Claude Vellefaux, 75010 Paris, France (elie
.azoulay@sls.ap-hop-paris.fr).
Clinical Infectious Diseases 2000;31:914–9
᭧ 2000 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2000/3104-0010$03.00
tion in medical intensive care unit (ICU) patients with pleural
effusions. We evaluated the value of the strips for separating
transudative from exudative effusions and then for categorizing
exudative infections as infectious or noninfectious.
Patients and Methods
Patients. From 1 December 1997 to 1 December 1998, 3 teach-
ing-hospital medical ICUs prospectively included all patients who
had a pleural effusion at or after admission to the ICU and who
were deemed by the ICU physicians to require exploratory
thoracentesis.
Pleural effusion was diagnosed clinically on the basis of absent
breath sounds at auscultation, flatness to percussion, and reduced
tactile fremitus. A chest radiograph was obtained to confirm the
diagnosis. The decision to perform exploratory thoracentesis was
based on the criteria normally used at each of the study centers.
Pleural fluid was obtained by insertion of an 8-mm needle and was
sent to the appropriate laboratories for biochemical tests (for pH
and levels of lactate dehydrogenase, protein, and glucose), micro-
biological studies (identification of pathogens in smears and cul-
tures), and cytological studies (leukocyte and lymphocyte counts).
The pleural fluid was then tested, by use of a reagent strip designed
for the testing of urine (Multistix 8SG; Bayer, Leverkusen, Ger-
many), by an investigator who was unaware of the results of the
test described above.
Data collection. The following information was collected for
each patient. Epidemiological and clinical data included sex, age,
comorbidities (chronic heart failure, chronic obstructivepulmonary
disease, immunodepression, cirrhosis, and neutropenia), the reason
for admission to the medical ICU (acute respiratory or renal failure,
shock, or coma), the severity score at admission (simplified acute
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018
CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 915
Table 1. Pathogens isolated from patients with microbiologically
documented pneumonia and from patients with empyema.
Documented infection
No. of
patients
Pneumonia
Branhamella catarrhalis 2
Enterobacter cloacae 1
Haemophilus influenzae 4
Proteus mirabilis 2
Pseudomonas aeruginosa 7
Staphylococcus aureus 3
Streptococcus pneumoniae 3
Streptococcus species 3
Total 25
Empyema
Escherichia coli 2
Klebsiella pneumoniae 2
Mycobacterium tuberculosis 2
Peptostreptococcus species 2
Staphylococcus aureus 3
Streptococcus species 3
Total 14
physiological score II [SAPSII] [9]), and presence or absence of
clinically or microbiologically documented infection at the time of
thoracentesis. Characteristics of the pleural effusion included bio-
chemical and cytological test findings (fluid/serum [F/S] ratios for
protein and lactate dehydrogenase, glucose level, leukocyte count,
and percentage of neutrophils); findings from Gram-stained smears
and cultures for bacteria, mycobacteria, and fungi; and results from
the reagent strip (protein and leukocyte esterase measurements and
pH). The cause of the effusion was determined on the basis of
clinical findings and results of laboratory tests of the pleural fluid
and serum. Reagent strip results were read by use of a colorimeter
(Clinitek 50; Bayer [10]) and were expressed on a 6-grade scale
(grades 0–5), for the protein and leukocyte esterase levels, and as
the value for the pH (range, 6–8.50, with intervals of 0.50). All 3
reagent strip results were assigned and collected by an investigator
who was unaware of the results of the other tests.
Criteria for the etiologic diagnosis of pleural effusion. Three
categories of pleural effusion were defined [8]. Transudative effu-
sion was defined as an F/S protein ratio !0.5; infectious exudative
effusion was defined as an F/S protein ratio у0.5 and either a
positive bacteriologic culture (empyema) or clinical or microbio-
logical evidence of pneumonia (parapneumonic effusion); and non-
infectious exudative effusion was defined as an F/S protein ratio
10.5 with negative bacteriologic cultures and no evidence of pneu-
monia.
Statistical analysis. The categories of patients defined above
were considered. Transudative effusions were compared with ex-
udative effusions, and infectious exudative effusions were com-
pared with noninfectious exudative effusions. These comparisons
were made by use of the x2
test or Fisher exact test, for categorical
variables, and by use of the Wilcoxon test or the Kruskal-Wallis
test, for continuous variables. Regression splines were used to ob-
tain a nonparametric estimate of the cutoff of continuous covar-
iates influencing the risk of each effusion category. A multivariate
logistic regression model was then constructed to determine the
OR of each reagent strip result for predicting whether any effusion
was exudative and whether an exudative effusion was infectious.
The percentage of each diagnosis established on the basis of con-
ventional tests was used as the reference and is hereafter referred
to as the “observed” percentage, as opposed to the “predicted”
percentage, which was established on the basis of reagent strip
findings. Continuous variables were dichotomized according to the
spline regression results. Values for Hosmer-Lemeshow goodness
of fit were computed, as were calibration curves (observed vs. pre-
dicted rates of each event). The SAS software package (SAS, Cary,
NC) was used for all statistical evaluations.
Results
Patient characteristics. From 1 December 1997 to 1 De-
cember 1998, 82 patients admitted to the 3 medical ICUs par-
ticipating in the study underwent thoracentesis for evaluation
of a pleural effusion.
The patients were 42 men and 40 women with a median age
of 59.5 years (25th–75th percentile, 42.5–69.5 years) and a me-
dian SAPSII score of 46 (25th–75th percentile, 27.7–46.5).
Seven patients (8.5%) were HIV infected, 18 (22%) had im-
munodepression resulting from other causes, and 8 (10%) were
receiving steroid therapy (daily administration of 11 mg of
prednisone or equivalent per kg for the past 30 days). Fourteen
patients (17%) had diabetes, 29 (35%) were alcoholics, 19 (23%)
had chronic obstructive pulmonary disease, and 13 (16%) had
documented chronic heart failure. The reasons for admission
to the ICU (patients could have more than 1 reason) and the
number and percentage of patients with each reason were as
follows: acute respiratory failure (67 patients [82%]), decom-
pensation of chronic respiratory failure (10 [12%]), shock (32
[39%]), cardiogenic pulmonary edema (19 [23%]), acute renal
failure (14 [17%]), coma (11 [13.5%]), and pulmonary embolism
(7 [8.5%]). Forty-five patients (55%) required mechanical ven-
tilation (of these, 33 [40%] had a positive end-expiratory pres-
sure of 15 cm H2O), 35 (42.5%) required vasopressor agents,
and 6 (7.5%) required dialysis.
On average, admission to the ICU occurred 1 day after ad-
mission to the hospital (25th–75th percentile, 0–7 days), and
exploratory thoracentesis was done within 2 days (25th–75th
percentile, 0–7 days) after admission to the ICU. The median
duration of stay in the ICU was 11 days (25th–75th percentile,
6–19 days), and the mortality rate in the ICU was 35% (29
deaths).
On the day of thoracentesis, 47 patients (57%) were taking
antibiotics and 28 (34%) were taking diuretics. Clinical evidence
of infection was present in 55 patients (67%), including 45 with
pneumonia, 3 with digestive infection, 2 with bacteremia, 2 with
skin and soft tissue infections, 1 with meningitis, 1 with urinary
tract infection, and 1 with catheter-related infection. Microbi-
ological documentation of an infection was obtained for 32 of
these patients (39%), including 25 of those with pneumonia
(table 1). Before thoracentesis, 5 pleural effusions were con-
firmed by chest sonogram and 3 were confirmed by CT scans;
for all other effusions, thoracentesis was done on the basis of
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018
916 Azoulay et al. CID 2000;31 (October)
Table 2. Results of conventional laboratory tests and of reagent strip testing of pleural fluid.
Test results
Type of pleural effusion
a
P
b
Transudative
( )n p 20
Infectious exudative
( )n p 35
Noninfectious exudative
( )n p 27
Conventional testing, median (25th–75th percentile)
pH 7.76 (7.54–8.15) 7.50 (7.39–7.94) 7.81 (7.54–8.00) .03
Fluid/serum protein ratio 0.29 (0.25–0.38) 0.58 (0.47–0.74) 0.57 (0.42–0.64) !.0001
Fluid/serum LDH ratio 0.46 (0.33–1.01) 2.41 (1.06–6.6) 0.73 (0.45–1.59) !.0001
Leukocyte count 131 (42–267) 1020 (100–2050) 250 (92–467) .005
Percentage of neutrophils 25 (11–40) 80 (63–85) 9 (1.7–20) !.0001
Reagent strip testing
c
, no. (%)
Protein grade 13 10 (50) 33 (94.3) 21 (77.7) .0006
Leukocytes grade 12 0 (0) 15 (42.8) 2 (7.4) .003
NOTE. LDH, lactate dehydrogenase.
a
According to the criteria of Light et al. [8].
b
By use of the Kruskal-Wallis test, for conventional findings, and by use of the x2
test, for reagent strip findings with the null
hypothesis that distribution of each variable was identical in the 3 groups.
c
Results not available for 4 patients with hemothorax.
clinical examination. The only adverse event related to thora-
centesis was pneumothorax, which occurred in 6 patients (7%).
Characteristics of the pleural effusion. Among the 82 ef-
fusions, 20 (24.4%) were transudates, 35 (42.7%) were infectious
exudative effusions associated with pneumonia (21 effusions)
or empyema (14 effusions) (table 1), and 27 (32.9%) were non-
infectious exudative effusions (of which 10 were malignancies,
4 were pulmonary embolisms, 4 were postoperative effusions
following upper abdominal surgery, 4 were hemothoraxes, 3
were effusions of unknown origin, and 2 were pancreatitis).
Gram-staining was positive for 6 (42.8%) of the 14 empyemas.
Table 2 reports the main findings from conventional pleural
fluid tests in the 3 patient categories as well as the results of
reagent strip testing (which was not performed for the 4 patients
with hemothorax). With the reagent strip, grade 3 was the pro-
tein level cutoff that distinguished transudative from exudative
effusions, and grade 2 was the leukocyte esterase cutoff that
distinguished infectious exudative from noninfectiousexudative
effusions (figure 1). Figure 2 displays the weak correlations
between pleural fluid pH, protein level, and leukocyte count,
either by use of the reagent strip or by use of a conventional
laboratory technique. Pleural fluid glucose levels were signifi-
cantly decreased only in the 14 patients with empyema (median,
1.7 mM/L [25th–75th percentile, 1.2–4.4 mM/L] vs. 7.9 mM/L
[25th–75th percentile, 5.5–10.1 mM/L] in patients with para-
pneumonic effusions [ ]; median, 6.4 mM/L [25th–75thP p .02
percentile, 5.1–9.2 mM/L] in patients with other effusions
[ ]). Moreover, all patients with a positive Gram stainP p .009
had a leukocyte esterase test result of grade у2. Otherwise, as
shown in table 2, pH was significantly lower in infectious ex-
udative effusions than in transudative or noninfectious exu-
dative effusions. Moreover, in patients with empyema, pH was
significantly lower than in other patients, both according to
laboratory findings (median pH, 7.46 [25th–75th percentile,
7.27–7.50] vs. 7.77 [25th–75th percentile, 7.50–8.00]; )P p .004
and according to results of reagent strips. There were 3 patients
with a pH of 7.00 and 8 patients with a pH of 7.50 among the
14 patients with empyema ( ).P p .03
Multivariate analysis. As shown in table 3, among the re-
agent strip findings, only the protein grade discriminated sig-
nificantly between exudates and transudates (sensitivity, 93.1%;
specificity, 50%; positive predictive value, 84.3%; negative pre-
dictive value, 71.5%; OR, 6.77; and 95% CI, 1.87–24). Similarly,
among the 58 patients with exudates, only a positive reagent
strip test for leukocyte esterase was significantly predictive of
infection (sensitivity, 42.8%; specificity, 91.3%; positive predic-
tive value, 88.2%; negative predictive value, 51.2%; OR, 4.46;
and 95% CI, 1.2–16.4).
Figure 3 compares the percentages of exudative effusions and
infectious effusions determined by use of conventional tests
(observed percentage) and by use of reagent strip testing (pre-
dicted percentage). Regardless of the type of effusion consid-
ered, it appears that rates of exudative or infectious effusion
observed by use of conventional laboratory tests are close to
those predicted by the results of reagent strip testing (P p
and , respectively, according to the MacNemar test)..32 P p .27
Discussion
Our 3-center prospective study compared the results of pleu-
ral fluid testing done by means of conventional methods with
those obtained by use of reagent strip testing among 82 ICU
patients with transudative, infectious exudative, or noninfec-
tious exudative pleural effusions. This classification of pleural
effusions is a valuable aid in the selection of the most appro-
priate management (e.g., treatment for heart failure or change
in antibiotic therapy and pleural drainage). Results of reagent
strip testing were not available for the 4 patients with hemo-
thorax. Data from the remaining 78 patients showed that pleu-
ral fluid protein level, as evaluated by use of the reagent strip,
was effective in discriminating between exudative and transu-
dative effusions (OR, 6.77). Moreover, in the 62 patients with
exudates, the reagent strip leukocyte esterase result, which was
available for 58 patients, accurately identified the cases of in-
fection (OR, 4.46). Among the patients with exudative effu-
sions, the percentages of infectious and noninfectious effusions
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018
CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 917
Figure 1. Nonparametric spline estimate (thick line; [thin lines de-
note 95% CI]) of regression function f that models influence on prob-
ability of detection of exudative effusions (top) or of discrimination of
infectious from noninfectious effusions (bottom) by use of grades for
protein or leukocyte esterase measurements obtained by reagent strip
testing.
Figure 2. Comparison of pleural fluid findings from conventional
laboratory tests (fluid/serum protein ratio, neutrophil percentage, and
pH) and from reagent strip testing (protein and leukocyte esterase level
and pH). Horizontal lines in each box plot represent (bottom to top)
10th, 25th, 50th (median), 75th, and 90th percentiles. Such plots allow
for comparison of distribution of each variable (y axes) among groups
defined by results of reagent strip testing (x axes). Distributions of
conventional laboratory tests were compared with categorical results
of reagent strip testing, by use of nonparametric Wilcoxon (A and
B) or Kruskal-Wallis (C) tests. *P ! .05.
predicted on the basis of the results of reagent strip testing were
very close to those determined on the basis of conventional
laboratory tests.
To our knowledge, reagent strips have not yet been tested
for their ability to identify a pleural effusion as an exudate or
as a manifestation of infection. Reagent strips have, however,
been validated for the determination of pleural fluid pH [6, 7].
In our study, pleural pH was not an independent predictor for
infection, but it was significantly lower for infectious effusions
than for noninfectious effusions, particularly in the case of em-
pyema. As suggested by other studies, low pH values, detected
by use of either reagent strip tests or laboratory tests, could be
used as an aid when chest tube drainage is discussed [11, 12].
Urine test strips accurately estimated the pleural protein
grade: 54 (84.3%) of the 64 patients with a reagent strip pleural
protein grade 13 had an exudate, and 54 (93.1%) of the 58
patients with exudates had a reagent strip pleural protein grade
13. Nevertheless, 10 of the patients with transudates also had
a protein grade 13. Of these 10 patients, 1 had congestive heart
failure with a bilateral pleural effusion and an F/S ratio for
protein of 0.75 because of pleural amyloidosis. In 4 patients
with hemostasis abnormalities, the pleural fluid was blood-
stained and consequently produced a reagent strip proteingrade
13.
Reagent strip testing for leukocyte esterase has been found
useful in the diagnosis of infections of many body fluids but
has not yet been tested for pleural effusions [2–4]. Of the 17
patients in our study who had a reagent strip leukocyte esterase
grade у2, 15 (88.2%) had an infectious exudative effusion. Fif-
teen (42.8%) of the 35 patients with an infectious exudative
effusion had a reagent strip leukocyte esterase grade у2, ac-
counting for the same sensitivity rate as the Gram stain. The
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018
918 Azoulay et al. CID 2000;31 (October)
Figure 3. Percentages of cases of exudative effusion (top) and infectious effusion (bottom) determined by results of reagent strip tests (predicted
percentage [denoted by the unshaded bars) and results of conventional laboratory tests (observed percentage [denoted by the shaded bars). L,
reagent strip leukocyte esterase grade (cutoff, grade 2); P, reagent strip protein grade (cutoff, grade 3).
grade was у2 for only 2 patients (8.7%) with noninfectious
exudative effusions and for none of the patients with transu-
dative effusions. Nevertheless, 20 patients with infectious ex-
udative effusions had a leukocyte esterase grade !2, a finding
perhaps ascribable in part to the fact that 2 patients had pleural
tuberculosis with a predominance of lymphocytes in their ef-
fusion and that most of the remaining patients were already
taking antibiotic therapy at the time of the thoracentesis.
The percentages of exudative effusions (infectious or non-
infectious) and of infectious exudative effusions predicted on
the basis of protein and leukocyte esterase findings from reagent
strip tests were very close to those determined on the basis of
conventional tests. This finding suggests that, in patients with
exudates, reagent strip leukocyte esterase testing may be val-
uable for providing rapid diagnostic orientation and for iden-
tifying pleural fluid specimens that require particular attention
from laboratory technicians because of an increased likelihood
of disease. Moreover, all patients with a positive result of Gram
staining of pleural fluid had results of grade у2 with the leu-
kocyte esterase test, and the sensitivities of these 2 tests are
equal [13]. Therefore, results of reagent strips could help ICU
physicians to maintain a high index of suspicion regarding in-
fectious pleural effusion and to alert the laboratories to shorten
the turnaround time for conventional laboratory tests to allow
for an adequate antibiotic treatment on the basis of the Gram
stain. Furthermore, reagent strips may provide sound infor-
mation on which to base immediate treatment decisions (e.g.,
whether to use antibiotics) in places where technical and/or
economic constraints reduce the availability of laboratory test-
ing, or before the results of conventional tests are available.
The epidemiology of pleural effusions in patients in medical
ICUs remains poorly known. Of the 82 patients included in
our 3-center prospective study, only 20 (24.4%) had transu-
dative effusions. In contrast, in a study that did not use a need
for thoracentesis as an inclusion criterion, Mattison et al. [14]
found that fluid overload was by far the most common cause
of pleural effusion. In our patients, infection was the leading
cause, and the bacteriologic profile was that usually observed
in community- or hospital-acquired infections in patients in
ICUs. Moreover, although many pleural fluid components have
been suggested as useful for the differentiation of exudates from
transudates, the tools widely used to determine the cause of a
pleural effusion remain the protein level, the F/S protein ratio,
and the leukocyte count [15, 16]. Our results suggest that re-
agent strips accurately predict the results of these conventional
tests and may deserve to be recommended as an ancillary tool
in the diagnostic assessment of potentially infectious pleural
effusions.
Valuable insights into the significance of pleural effusions in
patients in medical ICUs (i.e., as a symptom or syndrome) could
be obtained by performing exploratory thoracentesis, a pro-
cedure that has been proved safe [17], followed by examination
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018
CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 919
Table 3. Multivariate analysis of exudative effusions and infection
by use of 2 models.
Model and reagent strip result
No. of
patients OR (95% CI) P
Prediction of presence of exudate in 78 pa-
tients with available reagent strip results
Protein grade 13 64 6.77 (1.87–24) .003
Leukocyte grade 12 17 6.48 (0.69–60) .10
Glucose grade !2 39 0.72 (0.17–2.9) .64
pH !7.50 10 0.98 (0.3–3.2) .98
Prediction of presence of pleural infection in
58 patients with exudative effusions
Protein grade 13 54 0.38 (0.06–2.4) .32
Leukocyte grade 12 17 4.46 (1.2–16.4) .02
Glucose grade !2 30 0.93 (0.21–4) .92
pH !7.50 9 0.79 (0.25–2.4) .67
NOTE. , by the Hosmer-Lemeshow test.2
P 1 .05 x
of the fluid at the bedside by use of reagent strips. Further
studies in a large number of patients are needed to determine
the value of this rapid, easy-to-use, and inexpensive tool for
identification of pleural fluids that do not require more expen-
sive tests, notably the impact of its use on patient outcome.
References
1. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997;10:
476–81.
2. Moosa AA, Quortum HA, Ibrahim MD. Rapid diagnosis of bacterial men-
ingitis with reagent strips. Lancet 1995;345:1290–1.
3. DeLozier JS, Auerbach PS. The leukocyte esterase test for detection of cere-
brospinal fluid leukocytosis and bacterial meningitis. Ann Emerg Med
1989;18:1191–8.
4. Smalley DL, Doyle VR, Duckworth JK. Correlation of leukocyte esterase
detection and the presence of leukocytes in body fluids. Am J Med Technol
1982;48:135–7.
5. Levy M, Tournot F, Muller C, Carbon C, Yeni P. Evaluation of screening
tests for urinary infection in hospital patients. Lancet 1989;2:384–5.
6. Cheng DS, Rodriguez RM, Rogers J, Wagster M, Starnes DL, Light RW.
Comparison of pleural fluid pH values obtained using blood gas machine,
pH meter, and pH indicator strip. Chest 1998;114:1368–72.
7. Byrd RP Jr, Roy TM. Pleural fluid pH determination. Chest1998;113:1426–7.
8. Light RW, MacGregor I, Luchsinger PC, et al. Pleural effusion: the diagnostic
separation of transudates and exudates. Ann Intern Med 1972;77:507–13.
9. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score
(SAPS II) based on a European–North American multicenter study.
JAMA 1993;270:2957–63.
10. Pugia MJ, Lott JA, Luke KE, Shihabi ZK, Wians FH Jr, Phillips L. Com-
parison of instrument-read dipsticks for albumin and creatinine in urine
with visual results and quantitative methods. J Clin Lab Anal 1998;12:
280–4.
11. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis
in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med
1995;151:1700–8.
12. Light RW. Parapneumonic effusions and empyema. Clin Chest Med 1985;6:
55–62.
13. Ferrer A, Osset J, Alegre J, et al. Prospective clinical and microbiological
study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999;18:237–41.
14. Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA. Pleural
effusions in the medical ICU: prevalence, causes, and clinical implications.
Chest 1997;111:1018–23.
15. Kinasewitz GT. Transudative effusions. Eur Respir J 1997;10:714–8.
16. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discrim-
inate between exudative and transudative effusions. Chest 1997;111:
970–80.
17. Colt HG, Brewer N, Barbur E. Evaluation of patient-related and procedure-
related factors contributing to pneumothorax following thoracentesis.
Chest 1999;116:134–8.
Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234
by guest
on 18 March 2018

Mais conteúdo relacionado

Mais procurados

IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimMark David Lim
 
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...Freddy Flores Malpartida
 
DU PERF AND ABX
DU PERF AND ABX DU PERF AND ABX
DU PERF AND ABX NHS
 
Methods of clinical investigation
Methods of clinical investigationMethods of clinical investigation
Methods of clinical investigationBadaghaleez
 
An observational descriptive study of pattern of pathological changes in live...
An observational descriptive study of pattern of pathological changes in live...An observational descriptive study of pattern of pathological changes in live...
An observational descriptive study of pattern of pathological changes in live...AI Publications
 
Yin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertensionYin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertensionEdgar Geovanny Cardenas Figueroa
 
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...Dr. Victor Euclides Briones Morales
 
מאמר על היעילות של השיטה בחולים אונקולוגיים
מאמר על היעילות של השיטה בחולים אונקולוגייםמאמר על היעילות של השיטה בחולים אונקולוגיים
מאמר על היעילות של השיטה בחולים אונקולוגייםZachi Berger, Ph.D. MBA
 
Outpatient talc administration by indwelling pleural catheter for malignant e...
Outpatient talc administration by indwelling pleural catheter for malignant e...Outpatient talc administration by indwelling pleural catheter for malignant e...
Outpatient talc administration by indwelling pleural catheter for malignant e...marcela maria morinigo kober
 
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...Esther K
 
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...J-réné Nkeck
 
Ann rheum dis 2002-swan-493-8
Ann rheum dis 2002-swan-493-8Ann rheum dis 2002-swan-493-8
Ann rheum dis 2002-swan-493-8Thabet Al Ahmadi
 

Mais procurados (18)

IQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - LimIQT Quarterly Winter 2016 - Lim
IQT Quarterly Winter 2016 - Lim
 
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...
Guidance isth _management_of_coagulopathy_in_covid-19 Dr. Freddy Flores Malpa...
 
Open Journal of Surgery
Open Journal of SurgeryOpen Journal of Surgery
Open Journal of Surgery
 
DU PERF AND ABX
DU PERF AND ABX DU PERF AND ABX
DU PERF AND ABX
 
Methods of clinical investigation
Methods of clinical investigationMethods of clinical investigation
Methods of clinical investigation
 
An observational descriptive study of pattern of pathological changes in live...
An observational descriptive study of pattern of pathological changes in live...An observational descriptive study of pattern of pathological changes in live...
An observational descriptive study of pattern of pathological changes in live...
 
Absceso hepatico1
Absceso hepatico1Absceso hepatico1
Absceso hepatico1
 
Yin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertensionYin, l., . (2013). the surgical treatment for portal hypertension
Yin, l., . (2013). the surgical treatment for portal hypertension
 
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...
Day 3 versus day 1 disseminated intravascular coagulation score among sepsis ...
 
מאמר על היעילות של השיטה בחולים אונקולוגיים
מאמר על היעילות של השיטה בחולים אונקולוגייםמאמר על היעילות של השיטה בחולים אונקולוגיים
מאמר על היעילות של השיטה בחולים אונקולוגיים
 
Outpatient talc administration by indwelling pleural catheter for malignant e...
Outpatient talc administration by indwelling pleural catheter for malignant e...Outpatient talc administration by indwelling pleural catheter for malignant e...
Outpatient talc administration by indwelling pleural catheter for malignant e...
 
Advanced Journal of Vascular Medicine
Advanced Journal of Vascular MedicineAdvanced Journal of Vascular Medicine
Advanced Journal of Vascular Medicine
 
Elliott bennett guerrero - Recess trial NEJM 2015
Elliott bennett guerrero - Recess trial NEJM 2015Elliott bennett guerrero - Recess trial NEJM 2015
Elliott bennett guerrero - Recess trial NEJM 2015
 
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...
Glisodin, a vegetal sod with gliadin, as preventative agent vs atherosclerosi...
 
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...
Evaluation of Oxidative status of gout patients in a Cameroonian urban hospit...
 
Borzio2016 (1)
Borzio2016 (1)Borzio2016 (1)
Borzio2016 (1)
 
Ann rheum dis 2002-swan-493-8
Ann rheum dis 2002-swan-493-8Ann rheum dis 2002-swan-493-8
Ann rheum dis 2002-swan-493-8
 
Consensus non ev
Consensus non evConsensus non ev
Consensus non ev
 

Semelhante a Diagnosis of infection pleural effussion by reagen strips

IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...Abdullatif Al-Rashed
 
Evaluation of immunosuppressive ahai.pdf
Evaluation of immunosuppressive ahai.pdfEvaluation of immunosuppressive ahai.pdf
Evaluation of immunosuppressive ahai.pdfleroleroero1
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFOuriel Faktor
 
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...Kevin Jaglinski
 
BMJ Open-2016-Datta-
BMJ Open-2016-Datta-BMJ Open-2016-Datta-
BMJ Open-2016-Datta-Tracey Mare
 
The kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskThe kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskKevin Jaglinski
 
Hospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndromeHospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndromeDee Evardone
 
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...iosrphr_editor
 
nuevos criterios de sepsis
nuevos criterios de sepsisnuevos criterios de sepsis
nuevos criterios de sepsisVeronica Dubay
 
Antiretroviral bioanalysis methods of tissues and body biofluids
Antiretroviral bioanalysis methods of tissues and body biofluidsAntiretroviral bioanalysis methods of tissues and body biofluids
Antiretroviral bioanalysis methods of tissues and body biofluidsRutva Patel
 
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...Factors associated with coinfections in invasive aspergillosis_ a retrospecti...
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...MHAASAID
 

Semelhante a Diagnosis of infection pleural effussion by reagen strips (20)

XpertTBCExtrapulm.pdf
XpertTBCExtrapulm.pdfXpertTBCExtrapulm.pdf
XpertTBCExtrapulm.pdf
 
Is the Paris System Sufficient for Reporting Urinary Cytology?
Is the Paris System Sufficient for Reporting Urinary Cytology?Is the Paris System Sufficient for Reporting Urinary Cytology?
Is the Paris System Sufficient for Reporting Urinary Cytology?
 
1 s2.0-s0002934317307180
1 s2.0-s00029343173071801 s2.0-s0002934317307180
1 s2.0-s0002934317307180
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
Louvet et al-2007-hepatology
Louvet et al-2007-hepatologyLouvet et al-2007-hepatology
Louvet et al-2007-hepatology
 
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
( Journal Club ) Procalcitonin as a diagnostic biomarker of sepsis: A tertiar...
 
Evaluation of immunosuppressive ahai.pdf
Evaluation of immunosuppressive ahai.pdfEvaluation of immunosuppressive ahai.pdf
Evaluation of immunosuppressive ahai.pdf
 
biomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDFbiomarcare_journal.pone.0159522.PDF
biomarcare_journal.pone.0159522.PDF
 
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...The kSORT assay to detect renal transplant patients at risk for acute rejecti...
The kSORT assay to detect renal transplant patients at risk for acute rejecti...
 
BMJ Open-2016-Datta-
BMJ Open-2016-Datta-BMJ Open-2016-Datta-
BMJ Open-2016-Datta-
 
The kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High RiskThe kSORT Assay to Detect Renal Transplant Patients at High Risk
The kSORT Assay to Detect Renal Transplant Patients at High Risk
 
Hora and Keating journal.pone.0157340.PDF
Hora and Keating journal.pone.0157340.PDFHora and Keating journal.pone.0157340.PDF
Hora and Keating journal.pone.0157340.PDF
 
Hospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndromeHospital outbreak of middle east respiratory syndrome
Hospital outbreak of middle east respiratory syndrome
 
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...
Study of some Pulmonary Function Tests in Children with Sickle Cell Anemia: C...
 
1606471580
16064715801606471580
1606471580
 
7. hcv in mexico
7. hcv in mexico7. hcv in mexico
7. hcv in mexico
 
nuevos criterios de sepsis
nuevos criterios de sepsisnuevos criterios de sepsis
nuevos criterios de sepsis
 
Clin Infect Dis.-2007-Hoen-381-90
Clin Infect Dis.-2007-Hoen-381-90Clin Infect Dis.-2007-Hoen-381-90
Clin Infect Dis.-2007-Hoen-381-90
 
Antiretroviral bioanalysis methods of tissues and body biofluids
Antiretroviral bioanalysis methods of tissues and body biofluidsAntiretroviral bioanalysis methods of tissues and body biofluids
Antiretroviral bioanalysis methods of tissues and body biofluids
 
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...Factors associated with coinfections in invasive aspergillosis_ a retrospecti...
Factors associated with coinfections in invasive aspergillosis_ a retrospecti...
 

Último

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 

Último (20)

Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 

Diagnosis of infection pleural effussion by reagen strips

  • 1. 914 Rapid Diagnosis of Infectious Pleural Effusions by Use of Reagent Strips Elie Azoulay,1 Muriel Fartoukh,3 Richard Galliot,4 Fre´de´ric Baud,4 Ge´rald Simonneau,3 Jean-Roger Le Gall,1 Benoıˆt Schlemmer,1 and Sylvie Chevret2 1 Medical Intensive Care Unit and 2 Biostatistics Department, Saint Louis Teaching Hospital, Paris 7 University, 3 Medical and Respiratory Intensive Care Unit, Antoine Beclere Teaching Hospital, and 4 Medical Intensive Care Unit, Lariboisiere Teaching Hospital, Paris, France Reagent strips have not yet been tested for use in the diagnosis of infectious pleural effusions. A reagent strip was used to evaluate 82 patients with pleural effusions: 20 patients had tran- sudative effusions, 35 had infectious exudative effusions (empyema in 14 and parapneumonic effusion in 21), and 27 had noninfectious exudative effusions. Pleural fluid protein, as eval- uated by the reagent strip, proved accurate for the detection of exudative effusions (sensitivity, 93.1%; specificity, 50%; positive predictive value, 84.3%; negative predictive value, 71.5%; odds ratio [OR], 6.77; and 95% confidence interval [CI], 1.87–24). The reagent strip leukocyte es- terase test effectively detected infectious exudative effusions (sensitivity, 42.8%; specificity, 91.3%; positive predictive value, 88.2%; negative predictive value, 51.2%; OR, 4.46; and 95% CI, 1.2–16.4). Pleural pH was significantly predicted by the reagent strip but was of no as- sistance in categorization of exudative effusions as infectious or noninfectious. Compared with physical, laboratory, and microbiological data, the reagent strip was as accurate for estimation of percentages of infectious and noninfectious exudative effusions. Thus, reagent strips may be a rapid, easy-to-use, and inexpensive technique for discriminating transudative from exudative pleural effusions and for categorizing exudative pleural effusions as infectious or noninfectious. A pleural effusion must be characterized as transudative or exudative and, if exudative, as infectious or noninfectious. These distinctions are important for choosing the appropriate management, such as therapy for heart failure, drainage of an infectious exudative effusion, or microbiological documenta- tion and adequate antibiotics for empyema. Exploratory thora- centesis is classically indicated because, in combination with blood tests, examination of pleural fluid frequently provides the etiologic diagnosis [1]. Use of reagent strips has been proposed for the rapid di- agnosis of meningitis, ascites, and urinary tract infections [2–5] and has also been validated for determination of the pH of pleural effusions [6, 7]. However, reagent strips have not been tested for their accuracy in the determination of the levels of protein and leukocyte esterase in pleural fluid, 2 parameters that are of paramount importance for distinguishing transu- dates from exudates and for determining whether an exudate is due to an infection [8]. We conducted a prospective 3-center study to evaluate the performance of reagent strips in the diagnosis of pleural infec- Received 25 October 1999; revised 16 February 2000; electronically pub- lished 20 October 2000. The appropriate institutional review board approved the study, and all patients gave their informed consent. Reprints or correspondence: Dr. Elie Azoulay, Medical ICU, Saint Louis Teaching Hospital, 1, avenue Claude Vellefaux, 75010 Paris, France (elie .azoulay@sls.ap-hop-paris.fr). Clinical Infectious Diseases 2000;31:914–9 ᭧ 2000 by the Infectious Diseases Society of America. All rights reserved. 1058-4838/2000/3104-0010$03.00 tion in medical intensive care unit (ICU) patients with pleural effusions. We evaluated the value of the strips for separating transudative from exudative effusions and then for categorizing exudative infections as infectious or noninfectious. Patients and Methods Patients. From 1 December 1997 to 1 December 1998, 3 teach- ing-hospital medical ICUs prospectively included all patients who had a pleural effusion at or after admission to the ICU and who were deemed by the ICU physicians to require exploratory thoracentesis. Pleural effusion was diagnosed clinically on the basis of absent breath sounds at auscultation, flatness to percussion, and reduced tactile fremitus. A chest radiograph was obtained to confirm the diagnosis. The decision to perform exploratory thoracentesis was based on the criteria normally used at each of the study centers. Pleural fluid was obtained by insertion of an 8-mm needle and was sent to the appropriate laboratories for biochemical tests (for pH and levels of lactate dehydrogenase, protein, and glucose), micro- biological studies (identification of pathogens in smears and cul- tures), and cytological studies (leukocyte and lymphocyte counts). The pleural fluid was then tested, by use of a reagent strip designed for the testing of urine (Multistix 8SG; Bayer, Leverkusen, Ger- many), by an investigator who was unaware of the results of the test described above. Data collection. The following information was collected for each patient. Epidemiological and clinical data included sex, age, comorbidities (chronic heart failure, chronic obstructivepulmonary disease, immunodepression, cirrhosis, and neutropenia), the reason for admission to the medical ICU (acute respiratory or renal failure, shock, or coma), the severity score at admission (simplified acute Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018
  • 2. CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 915 Table 1. Pathogens isolated from patients with microbiologically documented pneumonia and from patients with empyema. Documented infection No. of patients Pneumonia Branhamella catarrhalis 2 Enterobacter cloacae 1 Haemophilus influenzae 4 Proteus mirabilis 2 Pseudomonas aeruginosa 7 Staphylococcus aureus 3 Streptococcus pneumoniae 3 Streptococcus species 3 Total 25 Empyema Escherichia coli 2 Klebsiella pneumoniae 2 Mycobacterium tuberculosis 2 Peptostreptococcus species 2 Staphylococcus aureus 3 Streptococcus species 3 Total 14 physiological score II [SAPSII] [9]), and presence or absence of clinically or microbiologically documented infection at the time of thoracentesis. Characteristics of the pleural effusion included bio- chemical and cytological test findings (fluid/serum [F/S] ratios for protein and lactate dehydrogenase, glucose level, leukocyte count, and percentage of neutrophils); findings from Gram-stained smears and cultures for bacteria, mycobacteria, and fungi; and results from the reagent strip (protein and leukocyte esterase measurements and pH). The cause of the effusion was determined on the basis of clinical findings and results of laboratory tests of the pleural fluid and serum. Reagent strip results were read by use of a colorimeter (Clinitek 50; Bayer [10]) and were expressed on a 6-grade scale (grades 0–5), for the protein and leukocyte esterase levels, and as the value for the pH (range, 6–8.50, with intervals of 0.50). All 3 reagent strip results were assigned and collected by an investigator who was unaware of the results of the other tests. Criteria for the etiologic diagnosis of pleural effusion. Three categories of pleural effusion were defined [8]. Transudative effu- sion was defined as an F/S protein ratio !0.5; infectious exudative effusion was defined as an F/S protein ratio у0.5 and either a positive bacteriologic culture (empyema) or clinical or microbio- logical evidence of pneumonia (parapneumonic effusion); and non- infectious exudative effusion was defined as an F/S protein ratio 10.5 with negative bacteriologic cultures and no evidence of pneu- monia. Statistical analysis. The categories of patients defined above were considered. Transudative effusions were compared with ex- udative effusions, and infectious exudative effusions were com- pared with noninfectious exudative effusions. These comparisons were made by use of the x2 test or Fisher exact test, for categorical variables, and by use of the Wilcoxon test or the Kruskal-Wallis test, for continuous variables. Regression splines were used to ob- tain a nonparametric estimate of the cutoff of continuous covar- iates influencing the risk of each effusion category. A multivariate logistic regression model was then constructed to determine the OR of each reagent strip result for predicting whether any effusion was exudative and whether an exudative effusion was infectious. The percentage of each diagnosis established on the basis of con- ventional tests was used as the reference and is hereafter referred to as the “observed” percentage, as opposed to the “predicted” percentage, which was established on the basis of reagent strip findings. Continuous variables were dichotomized according to the spline regression results. Values for Hosmer-Lemeshow goodness of fit were computed, as were calibration curves (observed vs. pre- dicted rates of each event). The SAS software package (SAS, Cary, NC) was used for all statistical evaluations. Results Patient characteristics. From 1 December 1997 to 1 De- cember 1998, 82 patients admitted to the 3 medical ICUs par- ticipating in the study underwent thoracentesis for evaluation of a pleural effusion. The patients were 42 men and 40 women with a median age of 59.5 years (25th–75th percentile, 42.5–69.5 years) and a me- dian SAPSII score of 46 (25th–75th percentile, 27.7–46.5). Seven patients (8.5%) were HIV infected, 18 (22%) had im- munodepression resulting from other causes, and 8 (10%) were receiving steroid therapy (daily administration of 11 mg of prednisone or equivalent per kg for the past 30 days). Fourteen patients (17%) had diabetes, 29 (35%) were alcoholics, 19 (23%) had chronic obstructive pulmonary disease, and 13 (16%) had documented chronic heart failure. The reasons for admission to the ICU (patients could have more than 1 reason) and the number and percentage of patients with each reason were as follows: acute respiratory failure (67 patients [82%]), decom- pensation of chronic respiratory failure (10 [12%]), shock (32 [39%]), cardiogenic pulmonary edema (19 [23%]), acute renal failure (14 [17%]), coma (11 [13.5%]), and pulmonary embolism (7 [8.5%]). Forty-five patients (55%) required mechanical ven- tilation (of these, 33 [40%] had a positive end-expiratory pres- sure of 15 cm H2O), 35 (42.5%) required vasopressor agents, and 6 (7.5%) required dialysis. On average, admission to the ICU occurred 1 day after ad- mission to the hospital (25th–75th percentile, 0–7 days), and exploratory thoracentesis was done within 2 days (25th–75th percentile, 0–7 days) after admission to the ICU. The median duration of stay in the ICU was 11 days (25th–75th percentile, 6–19 days), and the mortality rate in the ICU was 35% (29 deaths). On the day of thoracentesis, 47 patients (57%) were taking antibiotics and 28 (34%) were taking diuretics. Clinical evidence of infection was present in 55 patients (67%), including 45 with pneumonia, 3 with digestive infection, 2 with bacteremia, 2 with skin and soft tissue infections, 1 with meningitis, 1 with urinary tract infection, and 1 with catheter-related infection. Microbi- ological documentation of an infection was obtained for 32 of these patients (39%), including 25 of those with pneumonia (table 1). Before thoracentesis, 5 pleural effusions were con- firmed by chest sonogram and 3 were confirmed by CT scans; for all other effusions, thoracentesis was done on the basis of Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018
  • 3. 916 Azoulay et al. CID 2000;31 (October) Table 2. Results of conventional laboratory tests and of reagent strip testing of pleural fluid. Test results Type of pleural effusion a P b Transudative ( )n p 20 Infectious exudative ( )n p 35 Noninfectious exudative ( )n p 27 Conventional testing, median (25th–75th percentile) pH 7.76 (7.54–8.15) 7.50 (7.39–7.94) 7.81 (7.54–8.00) .03 Fluid/serum protein ratio 0.29 (0.25–0.38) 0.58 (0.47–0.74) 0.57 (0.42–0.64) !.0001 Fluid/serum LDH ratio 0.46 (0.33–1.01) 2.41 (1.06–6.6) 0.73 (0.45–1.59) !.0001 Leukocyte count 131 (42–267) 1020 (100–2050) 250 (92–467) .005 Percentage of neutrophils 25 (11–40) 80 (63–85) 9 (1.7–20) !.0001 Reagent strip testing c , no. (%) Protein grade 13 10 (50) 33 (94.3) 21 (77.7) .0006 Leukocytes grade 12 0 (0) 15 (42.8) 2 (7.4) .003 NOTE. LDH, lactate dehydrogenase. a According to the criteria of Light et al. [8]. b By use of the Kruskal-Wallis test, for conventional findings, and by use of the x2 test, for reagent strip findings with the null hypothesis that distribution of each variable was identical in the 3 groups. c Results not available for 4 patients with hemothorax. clinical examination. The only adverse event related to thora- centesis was pneumothorax, which occurred in 6 patients (7%). Characteristics of the pleural effusion. Among the 82 ef- fusions, 20 (24.4%) were transudates, 35 (42.7%) were infectious exudative effusions associated with pneumonia (21 effusions) or empyema (14 effusions) (table 1), and 27 (32.9%) were non- infectious exudative effusions (of which 10 were malignancies, 4 were pulmonary embolisms, 4 were postoperative effusions following upper abdominal surgery, 4 were hemothoraxes, 3 were effusions of unknown origin, and 2 were pancreatitis). Gram-staining was positive for 6 (42.8%) of the 14 empyemas. Table 2 reports the main findings from conventional pleural fluid tests in the 3 patient categories as well as the results of reagent strip testing (which was not performed for the 4 patients with hemothorax). With the reagent strip, grade 3 was the pro- tein level cutoff that distinguished transudative from exudative effusions, and grade 2 was the leukocyte esterase cutoff that distinguished infectious exudative from noninfectiousexudative effusions (figure 1). Figure 2 displays the weak correlations between pleural fluid pH, protein level, and leukocyte count, either by use of the reagent strip or by use of a conventional laboratory technique. Pleural fluid glucose levels were signifi- cantly decreased only in the 14 patients with empyema (median, 1.7 mM/L [25th–75th percentile, 1.2–4.4 mM/L] vs. 7.9 mM/L [25th–75th percentile, 5.5–10.1 mM/L] in patients with para- pneumonic effusions [ ]; median, 6.4 mM/L [25th–75thP p .02 percentile, 5.1–9.2 mM/L] in patients with other effusions [ ]). Moreover, all patients with a positive Gram stainP p .009 had a leukocyte esterase test result of grade у2. Otherwise, as shown in table 2, pH was significantly lower in infectious ex- udative effusions than in transudative or noninfectious exu- dative effusions. Moreover, in patients with empyema, pH was significantly lower than in other patients, both according to laboratory findings (median pH, 7.46 [25th–75th percentile, 7.27–7.50] vs. 7.77 [25th–75th percentile, 7.50–8.00]; )P p .004 and according to results of reagent strips. There were 3 patients with a pH of 7.00 and 8 patients with a pH of 7.50 among the 14 patients with empyema ( ).P p .03 Multivariate analysis. As shown in table 3, among the re- agent strip findings, only the protein grade discriminated sig- nificantly between exudates and transudates (sensitivity, 93.1%; specificity, 50%; positive predictive value, 84.3%; negative pre- dictive value, 71.5%; OR, 6.77; and 95% CI, 1.87–24). Similarly, among the 58 patients with exudates, only a positive reagent strip test for leukocyte esterase was significantly predictive of infection (sensitivity, 42.8%; specificity, 91.3%; positive predic- tive value, 88.2%; negative predictive value, 51.2%; OR, 4.46; and 95% CI, 1.2–16.4). Figure 3 compares the percentages of exudative effusions and infectious effusions determined by use of conventional tests (observed percentage) and by use of reagent strip testing (pre- dicted percentage). Regardless of the type of effusion consid- ered, it appears that rates of exudative or infectious effusion observed by use of conventional laboratory tests are close to those predicted by the results of reagent strip testing (P p and , respectively, according to the MacNemar test)..32 P p .27 Discussion Our 3-center prospective study compared the results of pleu- ral fluid testing done by means of conventional methods with those obtained by use of reagent strip testing among 82 ICU patients with transudative, infectious exudative, or noninfec- tious exudative pleural effusions. This classification of pleural effusions is a valuable aid in the selection of the most appro- priate management (e.g., treatment for heart failure or change in antibiotic therapy and pleural drainage). Results of reagent strip testing were not available for the 4 patients with hemo- thorax. Data from the remaining 78 patients showed that pleu- ral fluid protein level, as evaluated by use of the reagent strip, was effective in discriminating between exudative and transu- dative effusions (OR, 6.77). Moreover, in the 62 patients with exudates, the reagent strip leukocyte esterase result, which was available for 58 patients, accurately identified the cases of in- fection (OR, 4.46). Among the patients with exudative effu- sions, the percentages of infectious and noninfectious effusions Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018
  • 4. CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 917 Figure 1. Nonparametric spline estimate (thick line; [thin lines de- note 95% CI]) of regression function f that models influence on prob- ability of detection of exudative effusions (top) or of discrimination of infectious from noninfectious effusions (bottom) by use of grades for protein or leukocyte esterase measurements obtained by reagent strip testing. Figure 2. Comparison of pleural fluid findings from conventional laboratory tests (fluid/serum protein ratio, neutrophil percentage, and pH) and from reagent strip testing (protein and leukocyte esterase level and pH). Horizontal lines in each box plot represent (bottom to top) 10th, 25th, 50th (median), 75th, and 90th percentiles. Such plots allow for comparison of distribution of each variable (y axes) among groups defined by results of reagent strip testing (x axes). Distributions of conventional laboratory tests were compared with categorical results of reagent strip testing, by use of nonparametric Wilcoxon (A and B) or Kruskal-Wallis (C) tests. *P ! .05. predicted on the basis of the results of reagent strip testing were very close to those determined on the basis of conventional laboratory tests. To our knowledge, reagent strips have not yet been tested for their ability to identify a pleural effusion as an exudate or as a manifestation of infection. Reagent strips have, however, been validated for the determination of pleural fluid pH [6, 7]. In our study, pleural pH was not an independent predictor for infection, but it was significantly lower for infectious effusions than for noninfectious effusions, particularly in the case of em- pyema. As suggested by other studies, low pH values, detected by use of either reagent strip tests or laboratory tests, could be used as an aid when chest tube drainage is discussed [11, 12]. Urine test strips accurately estimated the pleural protein grade: 54 (84.3%) of the 64 patients with a reagent strip pleural protein grade 13 had an exudate, and 54 (93.1%) of the 58 patients with exudates had a reagent strip pleural protein grade 13. Nevertheless, 10 of the patients with transudates also had a protein grade 13. Of these 10 patients, 1 had congestive heart failure with a bilateral pleural effusion and an F/S ratio for protein of 0.75 because of pleural amyloidosis. In 4 patients with hemostasis abnormalities, the pleural fluid was blood- stained and consequently produced a reagent strip proteingrade 13. Reagent strip testing for leukocyte esterase has been found useful in the diagnosis of infections of many body fluids but has not yet been tested for pleural effusions [2–4]. Of the 17 patients in our study who had a reagent strip leukocyte esterase grade у2, 15 (88.2%) had an infectious exudative effusion. Fif- teen (42.8%) of the 35 patients with an infectious exudative effusion had a reagent strip leukocyte esterase grade у2, ac- counting for the same sensitivity rate as the Gram stain. The Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018
  • 5. 918 Azoulay et al. CID 2000;31 (October) Figure 3. Percentages of cases of exudative effusion (top) and infectious effusion (bottom) determined by results of reagent strip tests (predicted percentage [denoted by the unshaded bars) and results of conventional laboratory tests (observed percentage [denoted by the shaded bars). L, reagent strip leukocyte esterase grade (cutoff, grade 2); P, reagent strip protein grade (cutoff, grade 3). grade was у2 for only 2 patients (8.7%) with noninfectious exudative effusions and for none of the patients with transu- dative effusions. Nevertheless, 20 patients with infectious ex- udative effusions had a leukocyte esterase grade !2, a finding perhaps ascribable in part to the fact that 2 patients had pleural tuberculosis with a predominance of lymphocytes in their ef- fusion and that most of the remaining patients were already taking antibiotic therapy at the time of the thoracentesis. The percentages of exudative effusions (infectious or non- infectious) and of infectious exudative effusions predicted on the basis of protein and leukocyte esterase findings from reagent strip tests were very close to those determined on the basis of conventional tests. This finding suggests that, in patients with exudates, reagent strip leukocyte esterase testing may be val- uable for providing rapid diagnostic orientation and for iden- tifying pleural fluid specimens that require particular attention from laboratory technicians because of an increased likelihood of disease. Moreover, all patients with a positive result of Gram staining of pleural fluid had results of grade у2 with the leu- kocyte esterase test, and the sensitivities of these 2 tests are equal [13]. Therefore, results of reagent strips could help ICU physicians to maintain a high index of suspicion regarding in- fectious pleural effusion and to alert the laboratories to shorten the turnaround time for conventional laboratory tests to allow for an adequate antibiotic treatment on the basis of the Gram stain. Furthermore, reagent strips may provide sound infor- mation on which to base immediate treatment decisions (e.g., whether to use antibiotics) in places where technical and/or economic constraints reduce the availability of laboratory test- ing, or before the results of conventional tests are available. The epidemiology of pleural effusions in patients in medical ICUs remains poorly known. Of the 82 patients included in our 3-center prospective study, only 20 (24.4%) had transu- dative effusions. In contrast, in a study that did not use a need for thoracentesis as an inclusion criterion, Mattison et al. [14] found that fluid overload was by far the most common cause of pleural effusion. In our patients, infection was the leading cause, and the bacteriologic profile was that usually observed in community- or hospital-acquired infections in patients in ICUs. Moreover, although many pleural fluid components have been suggested as useful for the differentiation of exudates from transudates, the tools widely used to determine the cause of a pleural effusion remain the protein level, the F/S protein ratio, and the leukocyte count [15, 16]. Our results suggest that re- agent strips accurately predict the results of these conventional tests and may deserve to be recommended as an ancillary tool in the diagnostic assessment of potentially infectious pleural effusions. Valuable insights into the significance of pleural effusions in patients in medical ICUs (i.e., as a symptom or syndrome) could be obtained by performing exploratory thoracentesis, a pro- cedure that has been proved safe [17], followed by examination Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018
  • 6. CID 2000;31 (October) Rapid Diagnosis of Pleural Infection 919 Table 3. Multivariate analysis of exudative effusions and infection by use of 2 models. Model and reagent strip result No. of patients OR (95% CI) P Prediction of presence of exudate in 78 pa- tients with available reagent strip results Protein grade 13 64 6.77 (1.87–24) .003 Leukocyte grade 12 17 6.48 (0.69–60) .10 Glucose grade !2 39 0.72 (0.17–2.9) .64 pH !7.50 10 0.98 (0.3–3.2) .98 Prediction of presence of pleural infection in 58 patients with exudative effusions Protein grade 13 54 0.38 (0.06–2.4) .32 Leukocyte grade 12 17 4.46 (1.2–16.4) .02 Glucose grade !2 30 0.93 (0.21–4) .92 pH !7.50 9 0.79 (0.25–2.4) .67 NOTE. , by the Hosmer-Lemeshow test.2 P 1 .05 x of the fluid at the bedside by use of reagent strips. Further studies in a large number of patients are needed to determine the value of this rapid, easy-to-use, and inexpensive tool for identification of pleural fluids that do not require more expen- sive tests, notably the impact of its use on patient outcome. References 1. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997;10: 476–81. 2. Moosa AA, Quortum HA, Ibrahim MD. Rapid diagnosis of bacterial men- ingitis with reagent strips. Lancet 1995;345:1290–1. 3. DeLozier JS, Auerbach PS. The leukocyte esterase test for detection of cere- brospinal fluid leukocytosis and bacterial meningitis. Ann Emerg Med 1989;18:1191–8. 4. Smalley DL, Doyle VR, Duckworth JK. Correlation of leukocyte esterase detection and the presence of leukocytes in body fluids. Am J Med Technol 1982;48:135–7. 5. Levy M, Tournot F, Muller C, Carbon C, Yeni P. Evaluation of screening tests for urinary infection in hospital patients. Lancet 1989;2:384–5. 6. Cheng DS, Rodriguez RM, Rogers J, Wagster M, Starnes DL, Light RW. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998;114:1368–72. 7. Byrd RP Jr, Roy TM. Pleural fluid pH determination. Chest1998;113:1426–7. 8. Light RW, MacGregor I, Luchsinger PC, et al. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77:507–13. 9. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European–North American multicenter study. JAMA 1993;270:2957–63. 10. Pugia MJ, Lott JA, Luke KE, Shihabi ZK, Wians FH Jr, Phillips L. Com- parison of instrument-read dipsticks for albumin and creatinine in urine with visual results and quantitative methods. J Clin Lab Anal 1998;12: 280–4. 11. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am J Respir Crit Care Med 1995;151:1700–8. 12. Light RW. Parapneumonic effusions and empyema. Clin Chest Med 1985;6: 55–62. 13. Ferrer A, Osset J, Alegre J, et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999;18:237–41. 14. Mattison LE, Coppage L, Alderman DF, Herlong JO, Sahn SA. Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest 1997;111:1018–23. 15. Kinasewitz GT. Transudative effusions. Eur Respir J 1997;10:714–8. 16. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discrim- inate between exudative and transudative effusions. Chest 1997;111: 970–80. 17. Colt HG, Brewer N, Barbur E. Evaluation of patient-related and procedure- related factors contributing to pneumothorax following thoracentesis. Chest 1999;116:134–8. Downloaded from https://academic.oup.com/cid/article-abstract/31/4/914/376234 by guest on 18 March 2018